These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

534 related items for PubMed ID: 18622141

  • 1. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
    Butterfield JH, Weiler CR.
    Int Arch Allergy Immunol; 2008; 147(4):338-43. PubMed ID: 18622141
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. On the role of PGD2 metabolites as markers of mast cell activation in asthma.
    O'Sullivan S.
    Acta Physiol Scand Suppl; 1999 Apr; 644():1-74. PubMed ID: 10352758
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis.
    Ono E, Taniguchi M, Mita H, Fukutomi Y, Higashi N, Miyazaki E, Kumamoto T, Akiyama K.
    Clin Exp Allergy; 2009 Jan; 39(1):72-80. PubMed ID: 19128354
    [Abstract] [Full Text] [Related]

  • 8. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.
    Divekar R, Butterfield J.
    Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439
    [Abstract] [Full Text] [Related]

  • 9. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
    Proelss J, Wenzel J, Ko Y, Bieber T, Bauer R.
    J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
    [Abstract] [Full Text] [Related]

  • 10. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
    Alvarez-Twose I, González de Olano D, Sánchez-Muñoz L, Matito A, Esteban-López MI, Vega A, Mateo MB, Alonso Díaz de Durana MD, de la Hoz B, Del Pozo Gil MD, Caballero T, Rosado A, Sánchez Matas I, Teodósio C, Jara-Acevedo M, Mollejo M, García-Montero A, Orfao A, Escribano L.
    J Allergy Clin Immunol; 2010 Jun; 125(6):1269-1278.e2. PubMed ID: 20434205
    [Abstract] [Full Text] [Related]

  • 11. Biochemical diagnosis of systemic mast cell disorders.
    Roberts LJ, Oates JA.
    J Invest Dermatol; 1991 Mar; 96(3):19S-24S; discussion 24S-25S. PubMed ID: 2002247
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Systemic mastocytosis. A review of current diagnostic and therapeutic approaches].
    Pari F, Zamagni MD, Carnevali C, Pagani M, Rabbi C, Cantore M, Cavazzini G, Aitini E, Smerieri F.
    Recenti Prog Med; 1999 Mar; 90(3):169-72. PubMed ID: 10228358
    [Abstract] [Full Text] [Related]

  • 14. Mast cell tryptase: a review of its physiology and clinical significance.
    Payne V, Kam PC.
    Anaesthesia; 2004 Jul; 59(7):695-703. PubMed ID: 15200544
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Are gastrointestinal mucosal mast cells increased in patients with systemic mastocytosis?
    Siegert SI, Diebold J, Ludolph-Hauser D, Löhrs U.
    Am J Clin Pathol; 2004 Oct; 122(4):560-5. PubMed ID: 15487454
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Survey of Mast Cell Mediator Levels from Patients Presenting with Symptoms of Mast Cell Activation.
    Butterfield JH.
    Int Arch Allergy Immunol; 2020 Oct; 181(1):43-50. PubMed ID: 31722348
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.